Paul Hodgson
Paul Hodgson is an associate director business development at VIDO-InterVac
Articles
Advancing Adjuvants and Vaccine Delivery Systems for Better Vaccination Strategies
January 2nd 2010This article presents ongoing research at VIDO-InterVac for the development of safer and more effective adjuvants. These include adjuvants that stimulate innate immunity in the body and combination adjuvants.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: December 9th 2024 | Updated: December 26th 2024
Recap Key Industry Trends for Viral Clearance and NGS
Published: December 7th 2024 | Updated: December 26th 2024
Enhancing Quality Through Training
Published: July 20th 2020 | Updated: December 26th 2024
Contact BioPharm International Editors
Published: July 19th 2020 | Updated: December 26th 2024
Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars
